CN1741800A - 药物预防胆碱脂酶抑制剂中毒的方法和适合的活性组分及药剂 - Google Patents

药物预防胆碱脂酶抑制剂中毒的方法和适合的活性组分及药剂 Download PDF

Info

Publication number
CN1741800A
CN1741800A CNA2004800024123A CN200480002412A CN1741800A CN 1741800 A CN1741800 A CN 1741800A CN A2004800024123 A CNA2004800024123 A CN A2004800024123A CN 200480002412 A CN200480002412 A CN 200480002412A CN 1741800 A CN1741800 A CN 1741800A
Authority
CN
China
Prior art keywords
medicament
ethyl
active component
active substance
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800024123A
Other languages
English (en)
Chinese (zh)
Inventor
弗兰克·比彻
托马斯·希勒
弗兰克·西奥博尔德
阿哈龙·莱维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Israel Institute for Biological Research
Original Assignee
LTS Lohmann Therapie Systeme AG
Israel Institute for Biological Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG, Israel Institute for Biological Research filed Critical LTS Lohmann Therapie Systeme AG
Publication of CN1741800A publication Critical patent/CN1741800A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNA2004800024123A 2003-01-17 2004-01-16 药物预防胆碱脂酶抑制剂中毒的方法和适合的活性组分及药剂 Pending CN1741800A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10301851.4 2003-01-17
DE10301851A DE10301851A1 (de) 2003-01-17 2003-01-17 Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel

Publications (1)

Publication Number Publication Date
CN1741800A true CN1741800A (zh) 2006-03-01

Family

ID=32602728

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800024123A Pending CN1741800A (zh) 2003-01-17 2004-01-16 药物预防胆碱脂酶抑制剂中毒的方法和适合的活性组分及药剂

Country Status (9)

Country Link
US (1) US20060183796A1 (enExample)
EP (1) EP1585514A1 (enExample)
JP (1) JP2006516267A (enExample)
KR (1) KR20050104347A (enExample)
CN (1) CN1741800A (enExample)
BR (1) BRPI0406580A (enExample)
DE (1) DE10301851A1 (enExample)
IL (1) IL169687A0 (enExample)
WO (1) WO2004064829A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2936150B1 (fr) * 2008-09-19 2013-09-06 Dermathologiques D Uriage Lab Nouvelles compositions dermatologiques protectrices de la peau et des muqueuses
GB0809905D0 (en) * 2008-06-02 2008-07-09 Secr Defence A Transdermal drug delivery device
CA3193154A1 (en) * 2020-08-31 2022-03-03 Nobelpharma Co., Ltd. Patch for alleviating or treating symptoms of neurodegenerative disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
DK0606366T3 (da) * 1991-09-26 2003-10-06 Us Gov Health & Human Serv Substituerede phenseriner og phenylcarbamater af (-)-eserolin, (-)-N1-noreserolin og (-)-N1-benzylnoreserolin som specifikke inhibitorer af acetylcholinesterase
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE4342173A1 (de) * 1993-12-10 1995-06-14 Lohmann Therapie Syst Lts Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
US5807671A (en) * 1995-01-09 1998-09-15 Yissum Research Development Company Of Hebrew University Of Jerusalem Method of screening for genetic predisposition to anticholinesterase therapy
US6955819B2 (en) * 1998-09-29 2005-10-18 Zars, Inc. Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
JP4422342B2 (ja) * 1998-11-27 2010-02-24 ザノヒェミア・ファルマツォイティカ・アー・ゲー せん妄の治療へのコリン作動性中枢神経系エフェクターの使用
US6756385B2 (en) * 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives

Also Published As

Publication number Publication date
BRPI0406580A (pt) 2005-12-20
KR20050104347A (ko) 2005-11-02
EP1585514A1 (de) 2005-10-19
JP2006516267A (ja) 2006-06-29
US20060183796A1 (en) 2006-08-17
WO2004064829A1 (de) 2004-08-05
IL169687A0 (en) 2007-07-04
DE10301851A1 (de) 2004-07-29

Similar Documents

Publication Publication Date Title
JP6212104B2 (ja) オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑止性経皮製剤
EP1201233B1 (en) Transdermal dosage form
KR101444967B1 (ko) 활성 물질로서 부프레노르핀을 투여하기 위한 경피 치료 시스템
EP2286814B1 (en) Transdermal preparation containing palonosetron
JP7071958B2 (ja) メマンチン経皮送達システム
EP1720551B1 (en) Alkaloid formulations
KR100397361B1 (ko) 고중독성유기인신경독소,특히소만에의해야기되는중독의예방및예비치료를위한피소스티그민및스코폴아민의조합된경피투여를위한경피치료시스템및방법
KR20180054833A (ko) 첩부제
JPH05505190A (ja) フィゾスチグミンの投与のための装置及び方法
EP3434267A1 (en) Patch preparation having misuse prevention characteristics
CN1741800A (zh) 药物预防胆碱脂酶抑制剂中毒的方法和适合的活性组分及药剂
US6114347A (en) Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors
CN106794155A (zh) 贴附剂
EP3530289A1 (en) Oral pharmaceutical solutions comprising melatonin
CN1994307B (zh) 一种预防有机磷酸酯类化合物中毒的复方经皮给药制剂
CN106890166A (zh) 含有钙受体活性化合物的皮肤外用制剂
US11759445B2 (en) Use of Rivastigmine in preparation of anti-radiation medicament
KR100390870B1 (ko) 경피투여용 항구토제 조성물 및 이를 포함하는 제제
US20210290560A1 (en) Transdermal therapeutic system for dispensing scopolamine without a membrane
DE10301930A1 (de) Verfahren zur medikamentösen therapeutischen oder prophylaktischen Behandlung
CN119745840A (zh) 一种含vmat2抑制剂11-p4s的黏胶分散型透皮贴剂及其制备方法
HK40022735B (zh) 氨吡啶tts
HK40022735A (en) Fampridine tts
US20200237682A1 (en) Fampridine tts
HK1098684B (en) Alkaloid formulations

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060301